161 results
8-K
EX-99.1
CTLT
Catalent, Inc.
29 Aug 24
Catalent, Inc. Reports Fourth Quarter and Fiscal 2024 Results
7:47am
, purchased components and raw materials; changes in market access or healthcare reimbursement in the United States or internationally; fluctuations
8-K
EX-99.1
CTLT
Catalent, Inc.
8 May 24
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results
4:20pm
, including active pharmaceutical ingredients, excipients, purchased components and raw materials; changes in market access or healthcare reimbursement
DEFM14A
cbb0m9
15 Apr 24
Proxy related to merger
7:35am
PREM14A
ydo34
3 Apr 24
Preliminary proxy related to merger
4:31pm
8-K
EX-99.1
v9f85
9 Feb 24
Catalent, Inc. Reports Second Quarter Fiscal 2024 Results
8:04am
DEFA14A
r4sq3u
5 Feb 24
Additional proxy soliciting materials
5:22pm
DEFA14A
8wq8mefeaw4dg
5 Feb 24
Additional proxy soliciting materials
7:03am
8-K
EX-2.1
58utjup
5 Feb 24
Novo Holdings to Acquire Catalent
7:00am
8-K
EX-99.1
qane 20nlau9axe
5 Feb 24
Novo Holdings to Acquire Catalent
7:00am
8-K/A
EX-99.1
2hdws v0mg9jilo
8 Dec 23
Revised Financial Highlights
5:07pm
8-K/A
EX-99.2
kv3rr2p1di n8ck1ekp
8 Dec 23
Revised Financial Highlights
5:07pm